The global follow-on biologics market is set to grow at a specified CAGR during the forecast period. Biologic medicines constitute significance in terms of patient illnesses. The medicines are grown out of living cells under laboratory conditions since these are hard to manufacture, complex and large. The production of biologics is also referred as production of reference products as it involves inheritance of complex biologics and exclusive details of manufacturing process.
Follow-on biologics market is driven by medical advances in treatment for serious illnesses followed by rise in patient care and surge in medicine manufacture. In addition, surging demands for low cost biological drugs is stimulating the market growth. Drug manufacturers are now producing generic biopharmaceuticals, however, pricing remains a big concern. Increase in costs of healthcare treatment, expensive form of drugs and rise in population is likely to stimulate the market growth. However, uncertainties on outcome effect by consumption of biologics and stringent regulations is more likely to disturb the market growth during the forecast period.
Follow-on biologics market is segmented by type comprising insulin, growth hormones, interferons, fertility hormones, fusion proteins and monoclonal antibodies. Application segment for the market comprises blood disorders, chronic and autoimmune diseases and oncology diseases.
Geographical segmentation for the market spans North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America and Europe market is likely to grow at a higher rate due to rise in medical infrastructure and increase in activities pertaining to patient care. Increase in R&D activities for production of biosimilar & biologics drugs.
The key players profiled in the follow-on biologics market report are Allergan, Allozyne, Alteogen, Alvogen, Amarey Novamedical, AstaZeneca, Bionovis, Biosidus, Bioton, CCM Duopharma, CCL Pharmaceuticals, Celltrion, Chong Kun Dang, Centocor Ortho Biotech, CinnaGen, Compass Biotechnologies, Ranbaxy, Syngene Pharmaceutical, Takeda, Zenotech, Zheijan Huahai Pharmaceutical.
Leading players of Follow-on Biologics including:
• Teva Pahrmaceutical
• Samsung Biologics
• Dr. Reddy's Laboratories
• Stada Arzneimittel AG
Market split by Type, can be divided into:
• Recombinant Non-glycosylated Proteins
• Recombinant Glycosylated Proteins
• Recombinant Peptides
Market split by Application, can be divided into:
• Blood Disorders
• Chronic Diseases
• Autoimmune Diseases
• Growth Hormone Deficiency
• Infectious Diseases
Market split by Sales Channel, can be divided into:
• Direct Channel
• Distribution Channel
Market segment by Region/Country including:
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
Research Support Specialist, USA